Skip to main content

Is this the beginning of the end for the Iran deal?

Proponents of the nuclear pact fear the worst under a Trump administration.

U.S. Republican presidential candidate Donald Trump makes his way through the crowd after addressing a Tea Party rally against the Iran nuclear deal at the U.S. Capitol in Washington September 9, 2015. REUTERS/Jonathan Ernst/File Photo                  FROM THE FILES PACKAGE "THE CANDIDATES" - SEARCH CANDIDATES FILES FOR ALL 90 IMAGES - RTX2SFIW
Many wonder whether President-elect Donald Trump will take action to kill the Iran nuclear deal. Here, Trump makes his way through a crowd after addressing a Tea Party rally against the deal at the US Capitol in Washington when he was trying to win the Republican presidential nomination, Sept. 9, 2015. — REUTERS/Jonathan Ernst/

Advocates of the nuclear deal with Iran are convinced the pact is in mortal danger following Republican Donald Trump’s upset election.

Deal skeptics on Capitol Hill have already prepared a raft of bills that have a far better chance of making it into law with the threat of a White House veto now out of the way. But the president-elect himself can just as easily send what he’s called a “disastrous” deal to the dustbin of history by simply refusing to sign off on sanctions relief.

“That’s why I find it so hard to believe that the deal survives,” said Richard Nephew, a former State Department sanctions official who now heads the program on Economic Statecraft, Sanctions and Energy Markets at Columbia University. “At some point, [Trump] will have to make an affirmative decision to support its implementation.”

Under the deal, the United States isn’t scheduled to provide additional sanctions relief until October 2023, well into a second Trump term. But the deal does require the president to periodically extend waivers on sanctions that remain on the books, as long as Iran abides by its obligations under the deal.

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish